In Brief: Reg reform
Reg reform: Bipartisan compromise bill sponsored by Senate Majority Leader Dole (R-Kan.) and Sen. Johnston (D-La.) set for consideration on the Senate floor June 27. The measure is based mainly on Dole's reg reform bill, S 343, as reported out of the Judiciary Committee April 27 ("The Pink Sheet" May 1, T&G-6). The bill is opposed by the Clinton Administration...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth